MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

SOLID STATE FORMS OF MIRDAMETINIB AND PROCESS FOR PREPARATION THEREOF

CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOF

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

REAGENTS AND METHODS FOR ALIPHATIC CARBON-HYDROGEN BOND FUNCTIONALIZATION

AMINOXY ACID-BASED ANTIBACTERIAL COMPOUNDS AND METHODS THEREOF

Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

HDAC6 Inhibitors and Imaging Agents

CANNABINOID DERIVATIVES

Electrolytes for electrochemical energy storage

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Synthesis Of Benzodiazepine Derivatives

Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

NOVEL COMPOUNDS

Solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof

INHIBITORS OF CD40-CD154 BINDING

HALOGENATED PHENYLSULFONAMIDE HYDROXAMIC ACID COMPOUNDS, COMPOSITIONS AND USES THEREOF AS SELECTIVE HDAC6 INHIBITORS

HDAC6 inhibitors and imaging agents

SURFACE TREATMENT AGENT, SURFACE TREATMENT METHOD, AND REGION SELECTIVE FILM FORMATION METHOD FOR SURFACE OF SUBSTRATE

Electrolytes for electrochemical energy storage

Photoswitchable HDAC inhibitors

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

Synthesis of benzodiazepine derivatives

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and methods for improving lymphatic uptake, bioavailability, and solubility of therapeutic compounds

HDAC6 inhibitors and imaging agents

Phenyl and pyridinyl hydroxamic acids

18-20 member bi-polycyclic compounds

18-20 member bi-polycyclic compounds

Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone

Benzo-N-hydroxy amide compounds having antitumor activity

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

Method of converting a nitrile functional group into a hydroxamic functional group by using a peroxocobalt complex at room temperature and normal pressure

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Octahydroanthracene compound, preparation method and application thereof

Photoswitchable HDAC inhibitors

NEW COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES AND METHOD OF PRODUCTION OF THEREOF

“Multi-target” compounds with inhibitory activity towards histone deacetylases and tubulin polymerisation, for use in the treatment of cancer

Trifluoromethoylation of arenes via intramolecular trifluoromethoxy group migration

18-20 member bi-polycyclic compounds

Synthesis of benzodiazepine derivatives

Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

Phenyl and pyridinyl hydroxamic acids

Selective HDAC6 inhibitors

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Ethynylbenzene derivatives

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

HDAC6 inhibitors and their uses

18-20 MEMBER BI-POLYCYCLIC COMPOUNDS

NOVEL MOLECULES THAT SELECTIVELY INHIBIT HISTONE DEACETYLASE 6 RELATIVE TO HISTONE DEACETYLASE

Hydroxamic acids and uses thereof

Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

Selective HDAC6 inhibitors

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Hydroxamic acids and uses thereof

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone

Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors

N-hydroxybenzamides as HDAC inhibitors for the treatment of parasitic diseases

Phosphonium compound, epoxy resin composition including the same and semiconductor device prepared from the same

Photoswitchable HDAC inhibitors

Bis-acylated hydroxylamine derivatives

Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1

Substituted hydroxamic acids and uses thereof

HDAC Inhibitor Polymorphic Forms and Methods of Use

Carbamoylmethoxy- and Carbamoylmethylthio- and Carbamoylmethylamino Benzamides for Combating Invertebrate Pests

HDAC inhibitors and therapeutic methods using the same

HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF

Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties

Auxin biosynthesis inhibitor

Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties

Benzamide derivatives

FLUORINATED HDAC INHIBITORS AND USES THEREOF

Cathepsin cysteine protease inhibitors

Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field

COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME

N-hydroxy-benzamids for the treatment of cancer

Hydroxamates as therapeutic agents

Oxadiazine-substituted arylamides

Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

NEW INHIBITORS FOR TREATING DISEASES ASSOCIATED WITH AN EXCESS TRANSPORT OF HYALURONAN

Cathepsin cysteine protease inhibitors

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

INHIBITORS OF HISTONE DEACETYLASE

Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition

Bis-acylated hydroxylamine derivatives

VITAMIN-D-LIKE COMPOUNDS

Inhibitors of histone deacetylase

Hydroxamates as therapeutic agents

Cyclic hydrocarbon compounds for the treatment of diseases

Histone deacetylase inhibitors

Fluorene compound and pharmaceutical use thereof

Histone deacetylase inhibitors

N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS

5-substituted-2-phenylamino benzamides as MEK inhibitors

Benzamide derivative

Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same

5-Substituted-2-phenylamino benzamides as MEK inhibitors

Hydroxamates as therapeutic agents

COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS

Dioxazine-substituted arylamides

Znchelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors

Vitamin D-like compound

Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field

Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives

Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions

Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof

Hydroxamates as therapeutic agents

Hydroxamates as therapeutic agents

Hydroxamic acid derivatives and the preparation method thereof

Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

Novel hydroxamic acid containing amino acid derivatives

Cathepsin cysteine protease inhibitors

POTENTIATION OF ANTIFUNGAL COMPOUNDS

ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE

Alpha-amino acid derivatives with antiinflammatory activity

Inhibitors of Histone Deacetylase

Hydroxamates as therapeutic agents

Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

Hydroxamic acid esters and pharmaceutical use thereof

Zn-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors

Tricyclic hydroxamate and benzamide derivatives, compositions and methods

Benzamide derivative

4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors

Non-nucleoside reverse transcriptase inhibitors

Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof

Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions

Hydroxamic acid-containing amino acid derivatives

Hydroxamic acid derivatives and the method for preparing thereof

Compound inhibiting in vivo phosphorous transport and medicine containing the same

Diacylglycerol acyltransferase inhibitors

Aminobenzophenone compounds

Substituted tetracycline compounds

Cathepsin cysteine protease inhibitors

Hydroxamic acid derivatives having anti-inflammatory action

Novel bicyclic hydroxamates as inhibitors of histone deacetylase

Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors

4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors

Preparation of hydroxamic acids from esters in solution and on the solid phase

Cathepsin cysteine protease inhibitors

Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof

N-hydroxysuccinimide process for conversion of phenols to carboxamides

Hydroxamates as therapeutic agents

Process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof

Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids

Benzenedicarboxylic acid derivatives

N-(4 substituted phenyl)-anthranilic acid hydroxamate esters

Acetylene derivatives as inhibitors of histone deacetylase

Benzophenone derivatives or salts thereof

Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide

4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors